BachmanityInsanity
New Member
I think the sales market for these drugs just in the post surgery and acute trauma ER recovery use would be huge. So why haven’t they been approved with so much financial incentive to do that? Why haven’t more human trials been done around the angeogenesis and cancer concern, if there could be lots of profits? I must be missing something right, what is that guys?